The gene (ipi) for an intracellular proteinase inhibitor (BsuPI) from Bacillus subtilis was cloned and found to encode a polypeptide consisting of 119 amino acids with no cysteine residues. The deduced amino acid sequence contained the N-terminal amino acid sequence of the inhibitor, which was chemically determined previously, and showed no significant homology to any other proteinase inhibitors. Analysis of the transcription initiation site and mRNA showed that the ipi gene formed an operon with an upstream open reading frame with an unknown function. The transcriptional control of ipi gene expression was demonstrated by Northern (RNA) blot analysis, and the time course of transcriptional enhancement roughly corresponded to the results observed at the protein level. Strains in which the ipi gene was disrupted or in which BsuPI was overexpressed constitutively sporulated normally. Analysis of the time course of production of the intracellular proteinase and proteinase inhibitor in these strains suggested that BsuPI directly regulated the major intracellular proteinase (ISP-1) activity in vivo.
Bacillus subtilis cells produce extracellularly at least four serine proteinases (Apr, Epr, Bpf, and Vpr) and three metalloproteinases (NprA, NprB, and Mpr), all of which have been shown to be nonessential for normal growth and sporulation (15, 44, 50) . As for intracellular proteinases, four serine proteinases, ISP-1, ISP-2 (generally considered to be a trypsinlike proteinase), ISP-3, and a membrane-bound proteinase (29, 41-43, 46) , and a spore-germinating proteinase (Gpr) (48) are known. Among them, ISP-1 is the major intracellular proteinase, accounting for 80% of the intracellular azocollagen or azocasein hydrolytic activity, and is the most well characterized (5) . ISP-1 was thought to function in the degradation and turnover of bulk proteins during sporulation (5) . However, the gene encoding ISP-1 has already been cloned (17) and a mutant deficient in it was shown to sporulate normally (1) . Expression of the ISP-1 gene was shown to be regulated at the transcriptional level indirectly by SpoOA and various regulatory proteins (16, 34) . Transcription was enhanced at To, the earliest stage of sporulation, but ISP-1 activity was not detected in cells until about 4 h later (34) . Although the N-terminal 17-amino-acid sequence of the primary translational product was not found in purified ISP-1, it was reported that this cleavage was an artifact and not related to the activation of ISP-1 (39) . These results suggested that ISP-1 activity was masked posttranslationally and revealed when needed.
On the other hand, ISP-1 was found to be inhibited by an intracellular proteinaceous inhibitor of B. subtilis (26) . This inhibitor (designated BsuPI, in accordance with our proposal [40] ) was purified by two different groups (27, 31 ) and analyzed at the protein level (30) . Although there are some differences between the results obtained by the groups, BsuPI was reported to be a very thermostable protein with a molecular mass of about 16 kDa and the decrease in its cellular amount seemed to cause an increase in ISP-1 activity (27, 42) . Nishino and Murao reported that BsuPI strongly inhibited ISP-1 * Corresponding author. activity and was inactivated by a membrane-bound proteinase under acidic conditions when tested in vitro (30) . These results suggested that BsuPI inhibited ISP-1 activity through complex formation at an early stage of sporulation and that later BsuPI was inactivated by a membrane-bound proteinase, resulting in high ISP-1 activity. Therefore, for characterization of the exact function of BsuPI with special reference to sporulation, cloning of the BsuPI-encoding gene was deemed to be essential.
In addition, it was also reported that BsuPI contained no cysteine residues. Since the structural relationship between the disulfide bridge and the reactive site in serine proteinase inhibitors from eukaryotic organisms (20, 33) and Streptomyces species (28) is already well known, it would be interesting to determine how BsuPI inhibits ISP-1. In this report, cloning of the BsuPI-encoding gene and characterization of its structure and function are described.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and transformation. Escherichia coli XL1-blue (Stratagene) and BL21(DE3) (Novagen) were grown at 37°C in 2YT and M9 (37) or M9ZB (47), respectively, and then transformed by the method of Hanahan (13) . B. subtilis DB104 (15) was grown at 37°C in L broth (37) or 2 x SG (21) and then transformed by the method of Chang and Cohen (7) or Sadaie and Kada (35) . When required, ampicillin, kanamycin, and erythromycin were added at concentrations of 50, 5, and 10 p.g/ml, respectively. For molecular cloning, pBR322 (37) and its derivative pBR-AN3 (49) were used, and for sequencing, M13mpl8 and M13mpl9 (37) were used. For gene expression in E. coli, pET-1 Id (47) was used. In the gene disruption experiment, plasmid pUCI 18 (37) (Fig. 1) Construction of an in-frame lacZ fusion vector as a promoter probe. The promoterless lacZ gene was obtained from pMC1403 (6), digested with both BamHI and Dral, and then inserted into BamHI-SmaI-digested pUC118 (pUC-lacZ).
From the BsuPI-encoding gene and its flanking region, a 0.9-kb PstI-Hinfl fragment for an in-frame ipi-lacZ fusion and a 1.0-kb HindIII-BamHI fragment for orfl-lacZ were prepared, treated with T4 polymerase in the presence of all four deoxynucleoside triphosphates, and then inserted into the 5'-upstream region of the lacZ gene in pUC-lacZ. In-frame fusions were selected on the basis of the formation of blue colonies on 5-bromo-4-chloro-3-indolyl-,3-D-galactopyranoside (X-Gal)-containing plates and confirmed by nucleotide sequencing. The fusion genes thus constructed were isolated and inserted into appropriate sites of pUB110, to which the multicloning site region of pNU210 (49) was incorporated, in the direction avoiding readthrough from any promoters of the plasmid (24) and then introduced into B. subtilis. r-Galactosidase activity, due to the promoter activity of the inserted fragment, in B. subtilis was judged on the basis of the formation of blue colonies on X-Gal plates, and the activity in liquid culture was measured by the method of Miller (25) .
Disruption of the BsuPI-encoding gene by homologous recombination. pUB110 was partially digested with HaeIII, and the 1.0-kb DNA fragment containing the whole kanamycin resistance gene was recovered from the agarose gel after electrophoresis. The 1.0-kb HindIII-SphI fragment of the BsuPI-encoding gene ( Fig. 1) (31) , indicating that ORF3 encodes BsuPI ( Fig. 1 and 2 ).
The deduced amino acid sequence of BsuPI contained no cysteine residues, as reported previously (31) . Although it was reported that BsuPI contained no histidine residues (31) (Fig. 3) , an RNA of about 0.9 kb was specifically detected with the BsuPI gene probe (1.3-kb BamHI-SphI fragment in Fig. 1 ) but not with the 5'-upstream probe (1.0-kb HindIII-BamHI fragment) or the 3'-downstream probe (0.4-kb SphI-PstI fragment) (data not shown). As can be seen in Fig. 3 , an about 1.6-kb RNA was also detected, but this signal was detected with all of the probes described above (data not shown), suggesting that the band resulted from nonspecific hybridization with the probes. These results also suggest that the whole transcription unit of the BsuPI-encoding gene is contained in the 1.3-kb BamHI-SphIfragment (see below) and the 0.9-kb RNA is the mRNA for BsuPI synthesis. Expression of the BsuPI-encoding gene was enhanced at about To and continued to be so to at least T1 5 (Fig. 3) (Fig. 4) . In the region 5' upstream from this site, a -10 sequence for CD (GACGGTAT/consensus GCCGATAT) was found but a -35 sequence was not. No other promoter-like sequence for u factors of B. subtilis was found (18) . To determine whether ORFI is transcribed, a deoxyoligonucleotide with the sequence 5'-CGCCGATGATGACGATGA GTA-3', complementary to the sequence from nucleotides 274 to 294 (Fig. 2) , was used as a primer for reverse transcriptase.
However, no primer-extended product was observed. This result suggests that ORFi is not transcribed under the cultural condition employed.
Effects of constitutive overexpression and disruption of the BsuPI-encoding gene on sporulation. Strains containing a disruption of the BsuPI-encoding gene were constructed by insertion of a kanamycin resistance gene. Southern blot analysis was performed on chromosomal DNAs extracted from 12 kanamycin-resistant and erythromycin-sensitive clones, obtained as described in Materials and Methods, by using a 0.4-kb HindIII-NspV fragment labelled with 32P as a probe. subtilis, heat-resistant spores of the wild-type strain, DB104; one of the insertion mutants, 42pi; and a strain overexpressing the BsuPI-encoding gene, DB104(pUB-DH5), were counted as described in Materials and Methods. While the numbers of viable cells of these three strains per milliliter were 9.9 x 108, 2.1 X 108, and 1.1 x 10', respectively, the numbers of spores per milliliter were 5.9 x 108, 8 .0 x 107, and 3.9 x 108, respectively. As for B. subtilis 42pi and DB104(pUB-DH5), more than 98% of the colonies derived from spores retained the kanamycin resistance gene. Thus, the three strains can sporulate efficiently, indicating that BsuPI is not necessary for sporulation of B. subtilis.
Interaction of BsuPI with intracellular proteinase in vivo.
The time course of the intracellular proteinase and proteinase inhibitor activities was analyzed by using cell extracts of B.
subtilis DBI04, 42pi, and DBI04(pUB-DH5). As shown in Fig.   VOL. 175, 1993 on March 1, 2013 by PENN STATE UNIV http://jb.asm.org/ Downloaded from J. BACTERIOL. Fig. 3 and 5) . Furthermore, recombinant BsuPI with N-terminal methionine exhibited inhibitory activity toward subtilisin Carlsberg. These results demonstrated that BsuPI was active without posttranslational modification, such as removal of the N-terminal methionine and proteolytic processing, as was observed in the case of the proteinase inhibitor of B. brevis (40) . Therefore, growth phase-specific transcriptional activation of the BsuPIencoding gene may have some significance at the early stage of sporulation, regardless of its necessity for sporulation. Northern blot analysis also revealed that the BsuPI mRNA has a long 5'-upstream control region and that it might be transcribed as an operon with ORF2 (Fig. 2) . The Although only the -10 consensus sequence recognized by (J is found in the upstream sequence of the transcriptional initiation site and CjD is presumed to function in vegetative cells (18) , a mechanism involving cooperation of aD and some factor, like that of (A and SpoOA in sporulating cells, might be necessary for expression of the BsuPI-encoding gene (38) . Further study is needed to identify which u factor recognizes the promoter of the BsuPI-encoding gene.
Time course analysis of production of the intracellular proteinase and proteinase inhibitor in the BsuPI-deficient and -constitutive strains showed that BsuPI strongly inhibited the major proteinase (ISP-1) in vivo at least until T7, so that a lag between transcription of the ISP-I-encoding gene and the appearance of ISP-1 activity was seen (Fig. 5) . However, ISP-1 activity increased at T4, even during BsuPI-encoding gene transcription (Fig. 3) , and an abrupt increase of ISP-1 activity at T4 was observed in the wild-type strain, as well as in the BsuPI-deficient strain (Fig. 5) . These results cannot be explained simply by BsuPI inactivation by the membrane-bound proteinase, as was reported previously (30, 42, 43) , since the ISP-1 increase was observed even in the BsuPI-deficient strain.
The reason for these changes in ISP-1 activity is not clear, but they might have some relevance to the finding that ISP-1 is inhibited less by BsuPI from cells at later stationary phases (39) .
The BsuPI-deficient strain and the BsuPI-overexpressing strain sporulated efficiently. This indicates that BsuPI is not important for normal sporulation. Since an ISP-1-deficient strain also sporulates normally (1), the function of BsuPI was assumed to involve inhibition of ISP-1 activity, which might be harmful only at an early stage of sporulation. It may be noted that with a longer culture period (3 days), the BsuPI-deficient strain tended to lyse more easily than the normal strain in medium containing bonito extract instead of beef extract.
BsuPI was reported to contain no cysteine residues, as judged from amino acid composition analysis. Although the relationship between the disulfide bridge and the reactive site of proteinase inhibitors has been well characterized for eukaryotic inhibitors (20, 33) , no such relationship is known for bacterial inhibitors other than those from Streptomyces spp. (28) . Recently, proteinase inhibitor genes were cloned from gram-negative bacteria, E. coli (9, 23) , and Pseudomonas aeruginosa (11) . Their deduced amino acid sequences contained cysteine residues. We cloned an extracellular inhibitor (BbrPI)-encoding gene from B. brevis which also contained no cysteine residues (40) . Primary structure comparison seemed to be the first step for identification of the reactive site and characterization of the inhibitory mechanism for these cysteine-less inhibitors from bacilli, but BsuPI shows no homology to other inhibitors or even to BbrPI. This suggests that these inhibitors evolved through different pathways.
